NGS platforms Explore benchtop and production-scale instruments designed to help you choose the right platform for your needs. Data analysis NGS data analysis tools User-friendly, intuitive tools simplify sequencing data analysis, allowing you to focus on research and spend less time configuring workflo...
Despite this wealth of options, more platforms are being brought out frequently, and advances such as reduced error rate will enable their expanded use for food authenticity. This rapid expansion in the use of DNA sequencing has led to an equally rapid enlargement in sequence databases, and the...
Our sequencing platforms are prominent in the history of sequencing, and we strive to actively shape the future of sequencing technology. Getting started with sequencing Sequencing is the process of reading the nucleotides present in DNA or RNA molecules. There ...
Sequencing Platforms Microarray Scanners IVD Instruments All Instruments For every lab, everywhere Access NGS with unrivaled simplicity and unthinkable speed Meet the MiSeq i100 Series Kits & Reagents Library Preparation Kits Sequencing Reagents Microarray Kits Clinical Research Products IVD Products All...
Utilization of next-generation sequencing platforms in plant genomics and genetic variant discovery Genome-wide variant detection within a species is the primary initial step towards linking genotypic variation and phenotypes. The conversion of these gene... S Deschamps,MA Campbell - 《Molecular Breeding...
Future sequencing platforms will require less input DNA and reagents (zeptoliters down to a few molecules), and become more portable for diagnostic use in medical, agricultural, ecological and other field-based settings. With advancing technology, NGS is poised to play a crucial role in single-...
HealthOmics Micronbrane Medical Introduces PaRTI-Cular™ in Collaboration with Basepair and AWS to Advance Infectious Disease Testing Navigating NGS Data Analysis on AWS: Key Considerations for New-To Sequencing Life Sciences Organizations Complete Genomics and Basepair Announce Technology Integration ...
The global size of NGS-based RNA-sequencing market in terms of revenue was estimated to be worth $2.5 billion in 2022 and is poised to reach $5.5 billion by 2027, growing at a CAGR of 17.2% from 2022 to 2027.
LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicine development through large-scale genomics and the establishment of a preeminent clinical genomic resource using Illumina's next-generation sequencing (NGS) platforms. As...
There is a growing need for robust data analysis tools capable of handling vast volumes of sequencing data, deciphering intricate genomic patterns, and facilitating actionable interpretations. Technological advancements and innovations in NGS data analysis platforms are reshaping the landscape of genomic rese...